Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/jncics/pkaa120 http://scihub22266oqcxt.onion/10.1093/jncics/pkaa120 33554040!7853171!33554040     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JNCI+Cancer+Spectr 2021 ; 5 (1): Pkaa120 Nephropedia Template TP {{tp|p=33554040|t=2021. Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients |pdf=|usr=}}{{33554040}} gab.com Text Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients JO: JNCI Cancer Spectr http://www.kidney.de/pget.php?&tw=1&pmid=33554040 #FOAvip Cancer patients are a vulnerable population postulated to be at higher risk for severe coronavirus disease 2019 (COVID-19) infection. Increased COVID-19 morbidity and mortality in cancer patients may be attributable to age, comorbidities, smoking, health care exposure, and cancer treatments, and partially to the cancer itself. Most studies to date have focused on hospitalized patients with severe COVID-19, thereby limiting the generalizability and interpretability of the association between cancer and COVID-19 severity. We compared outcomes of SARS-CoV-2 infection in 323 patients enrolled in a population-based study before the pandemic (n = 67 cancer patients; n = 256 noncancer patients). After adjusting for demographics, smoking status, and comorbidities, a diagnosis of cancer was independently associated with higher odds of hospitalization (odds ratio = 2.16, 95% confidence interval = 1.12 to 4.18) and 30-day mortality (odds ratio = 5.67, 95% confidence interval = 1.49 to 21.59). These associations were primarily driven by patients with active cancer. These results emphasize the critical importance of preventing SARS-CoV-2 exposure and mitigating infection in cancer patients. Twit Text FOAVip Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients ????JNCI Cancer Spectr http://www.kidney.de/pget.php?&tw=1&pmid=33554040 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33554040 #FOAvip English Wikipedia <ref>{{Cite pmid|33554040}}</ref> Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients #MMPMID33554040 Sun L; Surya S; Le AN; Desai H; Doucette A; Gabriel P; Ritchie MD; Rader D; Maillard I; Bange E; Huang AC; Vonderheide RH; DeMichele A; Verma A; Mamtani R; Maxwell KN JNCI Cancer Spectr 2021[Feb]; 5 (1): Pkaa120 PMID33554040show ga Cancer patients are a vulnerable population postulated to be at higher risk for severe coronavirus disease 2019 (COVID-19) infection. Increased COVID-19 morbidity and mortality in cancer patients may be attributable to age, comorbidities, smoking, health care exposure, and cancer treatments, and partially to the cancer itself. Most studies to date have focused on hospitalized patients with severe COVID-19, thereby limiting the generalizability and interpretability of the association between cancer and COVID-19 severity. We compared outcomes of SARS-CoV-2 infection in 323 patients enrolled in a population-based study before the pandemic (n = 67 cancer patients; n = 256 noncancer patients). After adjusting for demographics, smoking status, and comorbidities, a diagnosis of cancer was independently associated with higher odds of hospitalization (odds ratio = 2.16, 95% confidence interval = 1.12 to 4.18) and 30-day mortality (odds ratio = 5.67, 95% confidence interval = 1.49 to 21.59). These associations were primarily driven by patients with active cancer. These results emphasize the critical importance of preventing SARS-CoV-2 exposure and mitigating infection in cancer patients. |Adult[MESH] |Aged[MESH] |COVID-19/*complications/epidemiology/virology[MESH] |Female[MESH] |Hospitalization/*statistics & numerical data[MESH] |Humans[MESH] |Intensive Care Units/*statistics & numerical data[MESH] |Male[MESH] |Middle Aged[MESH] |Neoplasms/*complications/mortality/therapy[MESH] |Odds Ratio[MESH] |Outcome Assessment, Health Care[MESH] |Pandemics[MESH] |Risk Factors[MESH] |SARS-CoV-2/physiology[MESH]Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer P(epmc).pdf DeepDyve Pubget Overpricing